Literature DB >> 8908317

Recent trends in the epidemiology of esophageal cancer. Comparison of epidermoid- and adenocarcinomas.

T N Moyana1, M Janoski.   

Abstract

This was a retrospective study of 306 consecutive patients with esophageal carcinoma seen at the Saskatoon Cancer Center from 1970 to 1992, making an annual incidence of approximately 2.7 percent per 100,000 population. The two main cancer types were (1) epidermoid carcinoma (199 patients or 69 percent), and (2) adenocarcinoma (81 patients or 28 percent). At the time of diagnosis, all patients had advanced disease with > 60 percent having extra-esophageal spread. Patient management was conventional with radiotherapy, surgery, chemotherapy, or combinations thereof being the mainstay of treatment. After a mean follow-up of 13 months, 82 percent of the patients had died of disease, 11 percent of other causes, and none were cured of disease. An analysis of the time trends showed an increasing incidence of both epidermoid carcinomas and adenocarcinomas, particularly the latter. There was a preponderance of distally located tumors in either group. The reasons for these trends in the pathobiology of esophageal carcinoma are not fully understood at this time.

Entities:  

Mesh:

Year:  1996        PMID: 8908317

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  Examination of tissue distribution of Helicobacter pylori within columnar-lined esophagus.

Authors:  V K Sharma; S E Demian; D Taillon; R Vasudeva; C W Howden
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  Cancer of the esophagus: histopathological sub-types in northern Uganda.

Authors:  O N Alema; B Iva
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

3.  Changing pattern of esophageal cancer incidence in New Mexico: a 30-year evaluation.

Authors:  Kenneth J Vega; M Mazen Jamal; Charles L Wiggins
Journal:  Dig Dis Sci       Date:  2009-08-18       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.